In-vitro Toxicology Testing Market Is Projected To Growing At An Estimated CAGR Of 10.5% From 2015 To 2022

Global In-Vitro Toxicology Testing Market is expected to reach USD 44.7 billion by 2022 growing at an estimated CAGR of 10.5% from 2015 to 2022, according to a new report by Grand View Research, Inc. This expected rise in demand can be ascribed to novel and promising technologies in analytical laboratories. 

Advancement in bioinformatics based research for development of efficient software algorithms in order to carry out efficient stimulation of in-silico animal models in determination of toxicological response is expected to influence sector growth through to 2022. 

Furthermore, rapid up gradation of databases that serve information for toxicity profiling and lethal dose determination of different compounds is anticipated to create significant potential for growth in this market during the forecast period. 

Rise in government imposed restrictions and guidelines on usage of animals for pre-clinical research and toxicology testing is also attributive towards estimated progress in this industry.

Additionally, increasing R&D in biotechnology sector for enhancement in cell based assays and cell culture techniques, is anticipated to impart significant growth potential in this sector. 

Full Research Report on Global In-vitro Toxicology Testing Market Analysis:
http://www.grandviewresearch.com/industry-analysis/in-vitro-toxicology-testing-market

Further key findings from the study suggest:

• Pharmaceutical and cosmetic industry together accounted for almost 65% of total revenue generated in this sector for 2014. This large share can be attributed to rapid novel product launches for treatment of different diseased conditions wherein toxicological testing is the pre-requisite step. 

• Cell culture technology contributed for over 42% of the revenue generated in the industry with respect to technology owing to critical role of cell culture in biotechnological development and cell based analysis 

• Omics technology is anticipated to register lucrative growth thereby driving demand due to advancement in sequencing methods and availability of different platforms depending on source and target sequence. 

• As a fundamental process in biopharmaceutical or pharmaceutical product development toxicological testing finds application in determination of systemic, dermal, & ocular toxicity as well as endocrine disruption 

• Amongst the above enlisted applications, dermal toxicity is expected to witness significant progress with a CAGR of approximately 13% due to comparatively higher incidence of side effects associated with skin after administration of several compounds. 

• North America accounted for the largest share of over 45% in revenue in 2014 owing to presence of significant number of sector players that are implementing advanced in-vitro technology. Furthermore, presence of stringent regulations pertaining to animal usage in toxicity analysis attributive towards high demand of in-vitro tests in this region. 

• Asia Pacific is expected to witness lucrative CAGR of over 11% from 2015 to 2022 due to rapid improvement in health care infrastructure in developing economies of this region which in turn contributes to regional progress in industry. 

• Key participants of in-vitro toxicology testing industry are Quest Diagnostics, Covance, Cyprotex, Alere, Inc, Charles River Laboratories, GE Healthcare, Thermo Fisher Scientific, Eurofins Scientific, Inc., Agilent Technologies, Catalent Pharma Solutions, Sigma Aldrich, and Bio-Rad. 

• These participants are involved in collaborations with bioinformatics research firms in order to develop novel in-silicoalgorithms for computational estimation of toxicity of pharmaceutical and chemical products. 

• Moreover, these market entities are also focusing on entering untapped regions in order to maintain their share in market revenue. 

View more reports of this category by Grand View Research at:
http://www.grandviewresearch.com/industry/clinical-diagnostics

Grand View Research has segmented Global In-Vitro Toxicology Testing Market on the basis of end use, technology, method, application, and region:

Global In-vitro Toxicology Testing Outlook, by End-use (Revenue, USD Million, 2012 - 2022)

• Pharmaceutical industry
• Cosmetics & household products
• Diagnostics
• Chemical industry
• Food industry

Global In-vitro Toxicology Testing Technology Outlook (Revenue, USD Million, 2012 - 2022)

• Cell culture technology
• High throughput technology
• Molecular imaging
• OMICS technology

Global In-vitro Toxicology Testing Outlook, by Application (Revenue, USD Million, 2012 - 2022)

• Systemic Toxicology
• Dermal Toxicity
• Endocrine Disruption
• Occular toxicity

Global In-vitro Toxicology Testing Outlook, by Method (Revenue, USD Million, 2012 - 2022)

• Cellular Assay
• Biochemical Assay
• In-Silico
• Ex-vivo

In-vitro Toxicology Testing Regional Outlook (Market Revenue in USD Million, 2012 - 2022 )

• North America
• Europe
• Asia Pacific
• RoW

View Press Release Of This Report by Grand View Research: http://www.grandviewresearch.com/press-release/global-in-vitro-toxicology-testing-market                 

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com

In Vitro Diagnostics (IVD) Quality Control Market Is Expected To Grow At A CAGR Of 3.7% During The Forecast Period 2014-2025

Global IVD Quality Control Market is expected to reach over USD 1.13 billion by 2024 according to a new report by Grand View Research, Inc.

The continually evolving technology-oriented changes in the diagnostics field and the growing requirement to ensure patient safety necessitate the implementation of quality assurance programs in various medical disciplines including radiology and point-of-care devices.

The patients rely on self-testing IVD devices for long-term disease management and hence it is important for such IVD devices to be checked for quality in terms of result reproducibility and validity in order to guarantee patient safety. The rising number of certified clinical laboratories offering dependable IVD-based diagnostic services directly correlates with increased patient confidence, thus driving the quality control market.

In addition to quality assessments, amendments to the regulatory framework are made intermittently to enhance the present quality standards with the main objective of safeguarding qualitative superiority of the diagnostic services rendered to patients.

In May 2016, the European Union passed an agreement to update the pre-existing regulations pertaining to IVD devices wherein the updates were in concern with raising the patient safety levels, particularly for disabled persons. Furthermore, the presence of third party quality control agencies for independent assessment of the IVD devices is expected to elevate the current safety standards, which is expected to further propel the market growth.

Full Research Report on Global In Vitro Diagnostics (IVD) Quality Control Market Analysis:
http://www.grandviewresearch.com/industry-analysis/in-vitro-diagnostics-ivd-quality-control-market

Further key findings from the study suggest:

• In 2015, the clinical chemistry segment dominated the IVD quality control market with a share of over 35%. The increasing demand for preventive medicine and the rapid transformation of clinical laboratories into highly automated and efficient businesses are some of the factors for its large market share.
• The molecular diagnostics is one of the fastest growing segments during the forecast period owing to the increasing technical complexity of molecular diagnostic testing coupled with the constant need for quality evaluation to ensure standards. The molecular diagnostics tests are of prime importance as the test outcomes enable healthcare practitioners make critical treatment decisions.
• The hospital segment held the largest share in 2015 due to the presence of highly advanced technology-based devices, such as Next Generation Sequencing (NGS), mass spectrophotometry, and microarrays, and the rising applications of the optimized quality-control procedures
• The North America contributed over 43% of the market share in 2015 attributable to the presence of over 150,000 registered diagnostics laboratories. The clinical laboratories are required to provide accurate results and maintain the accuracy standards in order to retain their license to operate.
• Many pharmaceutical companies are implementing the new draft guidance enforced by the U.S. FDA for data integrity on current Good Manufacturing Practices (cGMP).It provides information in relation to establishing robust operating procedures and strong quality management systems, obtaining high-quality raw materials, investigating quality deviations, and maintaining reliable diagnostic laboratories

View more reports of this category by Grand View Research at:
http://www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the IVD quality control market on the basis of application, type, end-use, and region:

IVD Quality Control Market Application Outlook, by Revenue (USD Million, 2013 - 2024)

• Clinical Chemistry
• Immunochemistry
• Hematology
• Molecular Diagnostics
• Coagulation
• Microbiology
• Others

IVD Quality Control Market Type Outlook, by Revenue (USD Million), 2013 - 2024

• Quality Controls
• Plasma-based Controls
• Serum-based Controls
• Whole Blood-based Controls
• Other IVD Quality Controls
• Data Management
• Quality Assurance Services

IVD Quality Control Market End-use Outlook, by Revenue (USD Million), 2013 - 2024

• Home-care
• Laboratory
• Hospitals
• Others

IVD Quality Control Market Regional Outlook, by Revenue (USD Million), 2013 - 2024

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• Japan
• China
• Latin America
• Brazil
• MEA
• South Africa

View Press Release Of This Report by Grand View Research: http://www.grandviewresearch.com/press-release/global-in-vitro-diagnostics-ivd-quality-control-market                

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com

Immunoprotein Diagnostic Testing Market Analysis By Type, Technology, Application, And Segment Forecast Up To 2025

Global Immunoprotein Diagnostic Testing Market is anticipated to reach USD 10.3 billion by 2025, according to a new report by Grand View Research, Inc. This growth can be attributed to the rising incidence of chronic diseases.

According to American Heart Association’s 2017 statistics, nearly 790,000 people experience heart attack every year in the U.S. In addition, stroke is responsible for 1 in every 20 deaths in the U.S. Hence, WHO is also taking initiatives to reduce the risk of cardiovascular diseases. As a result of the aforementioned factors, the demand for immunoprotein diagnostics is expected to rise in order to facilitate rapid diagnosis.

According to WHO, nearly 1.69 million deaths due to lung cancer were registered in 2015 throughout the world. Hence, fast and accurate diagnosis of such chronic diseases has become important to reduce the high mortality rate. Immunoprotein diagnostic devices and reagents have proved to be highly effective in rapidly detecting chronic diseases.

Technological advancements in the field of immunoprotein diagnostics have led to introduction of novel products. For instance, LIAISON XL, manufactured by DiaSorin, is a fully automated chemiluminescence analyzer that facilitates complete sample processing. It also measures and evaluates testing samples, thereby, enhancing the efficiency and throughput of the system.

Full Research Report On Global Immunoprotein Diagnostic Testing Market Analysis:
http://www.grandviewresearch.com/industry-analysis/immunoprotein-diagnostic-testing-industry

Further key findings from the study suggest:

• In 2016, immunoglobulin tests dominated the market owing to their frequent usage by healthcare professionals for diagnosing infectious or autoimmune disorders
• C-Reactive Protein (CRP) tests held a significant market share in 2016 due to the broad product portfolio of these assays and reagents
• Infectious disease testing held largest market share in 2016 owing to the increasing prevalence of infectious diseases and high applications of immunoprotein tests
• Enzyme-based immunoassays dominated the market in 2016 due to their frequent usage and availability of large number of products that possess this technology
• Chemiluminescence assay is anticipated to witness highest growth over the forecast period due to its high sensitivity and specificity
• North America dominated the market in 2016 due to rising prevalence of cancer & increase in mortality due to cancer-related diseases and favorable healthcare reimbursement scenario in the U.S.
• Some of the key players are Bio-Rad Laboratories, Inc.; F. Hoffmann-La Roche AG; Abbott Laboratories; Enzo Biochem, Inc.; Thermo Fisher Scientific, Inc.; DiaSorin S.p.A; bioMérieux SA; and Siemens Healthcare GmbH

View more reports of this category by Grand View Research at:
http://www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the Global immunoprotein diagnostic testing market on the basis of test type, application, technology, and region:

Immunoprotein Diagnostic Testing Test Type Outlook (Revenue, USD Million, 2014 - 2025)

• Complement System Proteins Diagnostic Tests
• Free Light Chain Diagnostic Tests
• Haptoglobin Diagnostic Tests
• Immunoglobulin Diagnostic Tests
• Prealbumin Diagnostic Tests
• C-Reactive Protein (CRP) Diagnostic Tests 

Immunoprotein Diagnostic Testing Application Outlook (Revenue, USD Million, 2014 - 2025)

• Infectious Disease Testing
• Oncology Testing
• Endocrine Testing
• Toxicology Testing
• Allergy Testing
• Autoimmune Disease Testing

Immunoprotein Diagnostic Testing Technology Outlook (Revenue, USD Million, 2014 - 2025)

• Radioimmunoassay
• Enzyme-based Immunoassay
• Chemiluminescence Assay
• Immunofluorescence Assay
• Immunoturbidity Assay
• Immunoprotein Electrophoresis

Immunoprotein Diagnostic Testing Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• Asia Pacific
• Japan
• China
• India
• Latin America
• Brazil
• Mexico
• MEA
• South Africa
• Saudi Arabia

View Press Release Of This Report by Grand View Research: http://www.grandviewresearch.com/press-release/global-immunoprotein-diagnostic-testing-market               

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com

Structural Foam Market Is Expected To Witness Growth At 5.8% CAGR During Forecast Period 2014-2025

Global Structural Foam Market is expected to reach USD 42.2 billion by 2025, according to a new report by Grand View Research, Inc.  The market is expected to witness growth at 5.8%CAGR owing to Increasing infrastructure spending, particularly on residential & commercial buildings, has been a key factor driving the market growth. Moreover, the rising demand from material handling, automobile, and electrical & electronics, is also likely to contribute to the product demand over the forecast period. 

Increasing construction spending, particularly in emerging markets of Brazil, China, India, Mexico, Russia, and South Africa is expected to drive injection molded structural foam demand in these regions. Besides, positive outlook of the global automotive and packaging industries coupled with versatile properties of structural foams including better heat and pressure resistance increases their application scope in various industries.

However, volatility in prices of essential raw materials along with the growing environmental issues concerning their disposal is anticipated to hamper the market growth during the forecast period. On account of these concerns, many of the industry participants are aiming to develop bio-based foams using the injection molding technique.

Key market players such as SABIC, One Plastic Group, and Covestro AG are among the companies involved in the production and distribution of the products and have established themselves as key market participants and have high integration throughout the value chain. 

Full Research Report on Global Structural Foam Market Analysis:
http://www.grandviewresearch.com/industry-analysis/structural-foam-market

Further key findings from the report suggest:

• The global structural foam demand was 4,059.0 kilo tons in 2016 and is projected to grow at a CAGR of 5.3% from 2017 to 2025
• Polyethylene foam segment was the largest product segment in 2016 and is expected to generate revenue over USD 15.62 billion by 2025
• Global structural foam in automotive segment was valued at USD 6.81 billion in 2016 and is projected to witness a growth at a CAGR of 6.2% over the forecast period
• The U.S. structural foam market in building & construction was 518.8 kilo tons in 2016 and is likely to reach an overall volume of 851.6 tons by 2025
• The market in Asia Pacific is anticipated to witness considerable growth over the next few years owing to various advances across key regions, especially in the India and China. In terms of revenue, the regional market is likely to grow at a CAGR of 6.4% from 2017 to 2025
• Key market participants include Armacell International S.A., BASF, Diab International AB, The Dow Chemical Company, SABIC, One Plastic Group, Covestro AG, Evonik Industries and others.

View more reports of this category by Grand View Research at:
http://www.grandviewresearch.com/industry-analysis/structural-foam-market

Grand View Research has segmented the Global Structural Foam Market on the basis of product, application, and region:

Structural Foam Product Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2025)

• Polyethylene
• Polypropylene
• Polystyrene
• Polyurethane
• Others

Structural Foam Application Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2025)

• Material Handling
• Building & Construction
• Automotive
• Electrical & Electronics
• Others

Structural Foam Regional Outlook (Volume, Kio Tons; Revenue, USD Million, 2014 - 2025)

• North America
• U.S.
• Europe
• Germany
• UK
• France
• Asia Pacific
• China
• India
• Japan
• Central & South America
• Middle East & Africa 

View Press Release Of This Report by Grand View Research: http://www.grandviewresearch.com/press-release/global-structural-foam-market              

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com

Automotive Flooring Market Is Expected To Grow At A CAGR Of 5.2% During The Forecast Period 2014-2025

Global Automotive Flooring Market is expected to reach USD 947.4 million by 2025, according to a new report by Grand View Research, Inc. The rapidly growing automotive industry across the globe has been and is expected to drive the overall market growth. Further, the changing consumer preferences towards enhanced passenger comfort and vehicle aesthetics is anticipated to propel market growth over the forecast period.

The increasing use of insulating mats and related products for carpet protection, comfort, and aesthetics in passenger cars is expected to drive the product demand in the near future. The growing importance of noise reduction and thermal insulation is also expected to have positive impacts on the product demand during the forecast period.

The demand for floor carpets in automobiles for the protection of floor is directly proportional to the demand for vehicles. The increasing production of LCV and HCV in Asia Pacific is expected to drive the product demand in commercial vehicles, mainly on account of the presence of a large number of major OEMs in economies such as China and India.

The industry is expected to witness the highest growth in the mats product segment, expected to grow at a CAGR of 6.0% during the forecast period, in terms of revenue. The presence of key manufacturers with a massive geographical reach such as ACC, AGM Automotive, and 3M Company, with a gamut range of carpets and mats, is expected to drive the overall industry demand over the forecast period. 

Full Research Report on Global Automotive Flooring Market Analysis:
http://www.grandviewresearch.com/industry-analysis/automotive-flooring-market

Further key findings from the report suggest:

• The automotive flooring market was valued at USD 608.0 million in 2016 and is expected to grow at a CAGR of 5.2% during the forecast period on account of the increasing global vehicle production.
• The polyurethane material segment accounted for the largest share of industry revenues in 2016, and is also expected to witness the highest growth over the forecast period at a CAGR of 6.0%, attributable to the increasing use of the material for the manufacture of auto components.
• Carpets accounted for the largest share among products, and this segment is slated to grow at a CAGR of 5.0% during the forecast period, mainly driven by automotive production and the growing need for advanced carpeting solutions for NVH reduction and sound damping.
• The automotive flooring market in Asia Pacific dominated the global industry, and is slated to witness growth to the tune of 5.9% during the forecast period, primarily on account of the rapidly-growing automotive production in the region.
• The key strategies adopted by the industry players include acquisitions and distribution agreements. For instance, AGM Automotive Inc. acquired Durmont Austria, a textile manufacturer involved in the production of carpets for commercial building and automotive applications.

View more reports of this category by Grand View Research at:
http://www.grandviewresearch.com/industry/plastics-polymers-and-resins

Grand View Research has segmented the Global Automotive Flooring Market on the basis of material, product, application, and region:

Automotive Flooring Material Outlook (Revenue, USD Million; 2014 - 2025)

• Polyurethane
• Polypropylene
• Nylon
• Rubber
• Others

Automotive Flooring Product Outlook (Revenue, USD Million; 2014 - 2025)

• Carpets
• Mats

Automotive Flooring Application Outlook (Revenue, USD Million; 2014 - 2025)

• Cars
• LCV
• HCV

Automotive Flooring Regional Outlook (Revenue, USD Million; 2014 - 2025)

• North America
• U.S
• Europe
• Germany
• UK
• Asia Pacific
• China
• India
• Japan
• Central & South America
• Brazil
• Middle East & Africa
• South Africa

View Press Release Of This Report by Grand View Research: http://www.grandviewresearch.com/press-release/global-automotive-flooring-market             

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com

Nylon 6 And 66 Market Is Expected To Witness Growth At 6.1% CAGR During Forecast Period 2014-2025

Global Nylon 6 & 66 Market is expected to reach USD 41.13 billion by 2025, according to a new report by Grand View Research, Inc.The market is expected to witness growth at 6.1% CAGR owing to Increasing focus on fuel efficient and less polluting vehicles has forced the manufacturers to shift their focus from metals to plastics. Nylon being lightweight and heat resistant, has caught the attention of auto-manufacturers. Extensive demand from automotive industry is expected to trigger the nylon market growth. 

Nylon 6 holds the largest consumption share in the total nylon resin market, with most of the demand being generated from the textile industry. However, there is an increasing trend of nylon 66 consumption from the engineering plastic industry which is rampantly using nylon 66 to manufacture plastic products, replacing PVC.

There has been a disruption in the supply chain of the nylon value chain, as raw material caprolactam was oversupplied by the Asian manufacturers in the market. This trend had an adverse effect on the caprolactam prices resulting in shutdown of manufacturing units in North America and Europe.

Nylon 6 and 66 prices witnessed an increase in 2017 but are expected to hold stable in the forecasted years. Asia is predicted to hold a strong presence in the nylon 6 value chain while North America will successfully stabilize its nylon 66 capacity in the forecasted period.

Full Research Report on Global Nylon 6 & 66 Market Analysis:
http://www.grandviewresearch.com/industry-analysis/nylon-6-6-market

Further key findings from the report suggest:

• Nylon-6 dominates the global market with around 60% of total demand in 2016
• Nylon demand from automotive segment to reach a valuation of USD 11.26 billion by 2025. Increasing adaptation of nylon 66 in engineering plastics to replace traditional plastic has been responsible for the market growth.
• Consumption of nylon (6 and 66) resins is expected to reach 2.8 million tons by 2025 in Europe alone
• Caprolactam production and consumption in Asia Pacific is expected to increase as key nylon manufacturers in the region are expanding their production capacity
• Nylon manufacturers are showing a trend of backward and forward integration to attain mature position in the nylon market
• Asia Pacific is the epicenter of nylon 6 production whereas Europe and North America are expected to attain a strong hold in the nylon 66 market by the end of 2025

View more reports of this category by Grand View Research at:
http://www.grandviewresearch.com/industry/plastics-polymers-and-resins

Grand View Research has segmented the Global Nylon 6 & 66 Market on the basis of product, application, and region:

Product Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2025)

• Nylon 6
• Nylon 66

Application Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2025)

• Automobile        
• Electrical & electronic
• Engineering plastics
• Textile
• Others

Regional Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2025)

• North America
• U.S.
• Europe  
• Germany
• France
• UK
• Asia-Pacific
• China
• India
• Japan
• South Korea
• MEA
• CSA

View Press Release Of This Report by Grand View Research: http://www.grandviewresearch.com/press-release/global-nylon-6-66-market            

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com

Injection Molded Plastic Market Demand Was95.91 Million Tons In 2014 And Is Expected To Reach 133.63 Million Tons By 2022

Global Injection Molded Plastic Market is expected to reach USD 295.89 billion by 2022, according to a new report by Grand View Research, Inc. Increasing penetration for automotive applications coupled with increasing infrastructure spending particularly in Asia Pacific and Latin America is expected to remain a key driving factor for global injection molded plastics over the forecast period. Positive outlook on global packaging industry is also projected to have a positive influence on the market growth. 

Volatile raw materials prices of major raw materials such as ethylene and propylene are expected to remain a key challenge for market participants. Commercialization of large scale production lines with variable molds along with technological innovations by key industry participants is expected to create new avenues for key industry participants. 

Polypropylene emerged as the leading raw materials with demand share exceeding 35% in 2014. Increasing polypropylene demand for rigid packaging is expected to drive its demand over the forecast period. The product is also expected to witness the highest growth of 4.5% from 2015 to 2022.The high rate of penetration of finished goods in packaging and construction materials may be attributed to high growth. 

Full Research Report on Global Injection Molded Plastic Market Analysis:
http://www.grandviewresearch.com/industry-analysis/injection-molded-plastics-market

Further key findings from the report suggest:

• The global injection molded plastics demand was95.91 million tons in 2014 and is expected to reach 133.63 million tons by 2022, growing at a CAGR of 4.2% from 2015 to 2022
• Packaging was the leading application segment and accounted for 33.4% of total market volume in 2014. The segment is anticipated to witness moderate growth with significant demand coming from rigid packaging for personal care and food storage industry.
• Injection molded plastics demand in medical applications is anticipated to witness the highest growth over the forecast period. The segment is anticipated to grow at a CAGR of 4.8% in terms of demand from 2015 to 2022.
• Asia Pacific was the leading regional market with demand share estimated at 37.5% in 2014. Increasing construction spending coupled with increasing automobile production in China, Indonesia and India is expected to remain a key driving factor for the regional market.
• Key players operating in the global industry include ExxonMobil, LyondellBasell, Eastman Company, Huntsman Corporation, Dow Chemicals, BASF, DuPont, SABIC, Eastman Chemical Company, Ineos Group, Magna International Inc. and HTI Plastics

View more reports of this category by Grand View Research at:
http://www.grandviewresearch.com/industry/plastics-polymers-and-resins

Grand View Research has segmented the Global Injection Molded Plastic Market on the basis of raw material, application and region:

Global Injection Molded Plastic Raw Material Outlook (Volume, Kilo Tons; Revenue, USD Million, 2012 - 2022)

• Polypropylene
• ABS
• HDPE
• Polystyrene
• Others

Global Injection Molded Plastic Application Outlook (Volume, Kilo Tons; Revenue, USD Million, 2012 - 2022)

• Packaging
• Consumables & Electronics
• Automotive
• Building & Construction
• Medical
• Others

Global Injection Molded Plastic Regional Outlook (Volume, Kilo Tons; Revenue, USD Million, 2012 - 2022)

• North America
• U.S.
• Europe
• Germany
• UK
• Italy
• Asia Pacific
• China
• India
• Japan
• Middle East & Africa
• Saudi Arabia
• Central & South America
• Brazil

View Press Release of this Report By Grand View Research: http://www.grandviewresearch.com/press-release/global-injection-molded-plastics-market   

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com